← Back to Catalog
Clinician access
Cagrilintide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Clinician Only
Metabolic & Foundational
Cagrilintide
Cagrilintide is a long-acting amylin analogue designed to reduce appetite, slow gastric emptying, and support sustained weight loss. It works through a separate pathway to enhance satiety and improve metabolic control.
Available Vials
- Delivery
- Subcutaneous Injection
- Starting Dose
- 0.1mg to 0.3mg once weekly
- Titration
- Increase slowly to 0.6mg–1.2mg weekly based on tolerance
- Sourcing
- Compounded in USA
Quantity
Continue Browsing1
More in Metabolic & Foundational
Tirzepatide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Tirzepatide
Subcutaneous Injection
Semaglutide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Semaglutide
Subcutaneous Injection
Retatrutide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Retatrutide
Subcutaneous Injection
Sign in to view full clinical details
Reconstitution, contraindications, clinic pricing, patient handouts, monitoring cadence, and drug interactions are available to verified clinicians.